Navigation Links
Enigma Diagnostics Announces a European Commission Award of EUR3 Million to Fund the Development of a Point of Care Platform for the Rapid Diagnosis of Influenza Infections
Date:10/3/2007

A Fully Automated, Portable Solution for In-Clinic and Out-Reach Influenza

Testing

PORTON DOWN, England, October 3 /PRNewswire/ -- Enigma Diagnostics, the life sciences company developing rapid molecular diagnostics and detection systems, announces a EUR3 million award from the European Commission Framework 7 programme to the RANGER consortium. The award will fund the development and validation of a fully automated, low cost system for the rapid diagnosis of influenza infections and subtypes.

The RANGER consortium, which is coordinated by Enigma Diagnostics, comprises leading technology companies including Applied Biosystems, Sagentia, Tico Europe, Bruhn Newtech Group, Bioplastics BV and PERA who will contribute to the development of the instrument and assays. The consortium also includes the Health Protection Agency, the UK's national reference laboratory for influenza diagnostics, and the Queen Sirikit National Institute of Child Health who will evaluate and validate the system.

The system will be based on Enigma's proprietary and fully-automated instrumentation technology, which integrates sample preparation with real-time polymerase chain reaction (PCR) to detect viral RNA in a full range of clinical samples. The simple-to-use, portable system will provide rapid results direct to medical staff in a near-patient or out-reach environment in both the developed and developing world.

By providing laboratory standard, high specificity and sensitivity PCR results in a decentralised setting, the system will advance the diagnosis of early stage viral infections and the surveillance of disease outbreaks.

Enigma is also separately developing real-time PCR-based diagnostics systems targeting chlamydia, gonorrhoea and other sexually transmitted infections.

John McKinley, Chairman of Enigma Diagnostics, said: "The award of this grant and the strength of our consortium partners is a great endorsement
'/>"/>

SOURCE Enigma Diagnostics Limited
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Roche Diagnostics Corporation
2. Roche Diagnostics Corporation
3. A prognosis for GE and Abbott Diagnostics
4. The world of in-vitro diagnostics is another Midwest success story
5. The world of in vitro diagnostics is another Midwest success story
6. Midwest holds strong position in worldwide diagnostics business
7. BioDiagnostics is first seed-testing lab to gain new accreditation
8. Speaker announces business members of IT Task Force
9. Doyle announces technology tax credits for Berbee
10. Doyle announces new energy, global warming policies
11. Doyle announces $80M renewable energy strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Bed bugs have become so widespread in ... many turn to chemical-based pesticides for help to completely get ... risks those solutions present, the company advised the public to ... , According to My Cleaning Products, chemical-based pesticides are ... be. It shared that the pests have already developed immunity ...
(Date:5/21/2013)... Inflamax scientists worked closely with ... design the study, which will provide critical insight ... used in the study of allergy treatments, the ... (NAC) models. Although both the models are well ... no direct comparison between the allergic responses evoked ...
(Date:5/21/2013)... SoundConnect is pleased to announce the release ... in Canada. Lync is the next generation of ... and organizations to collaborate and communicate much more easily ... the United States. With the progressive rollout of Lync ... Canada, SoundConnect now offers a complete Microsoft Lync solution ...
(Date:5/21/2013)... 2013 Clinovo's new “CDISC Standards: ... program starting on June 11th, 2013. The TechTrainings are ... reach the next step in their professional career. The ... Alto, and streamed online. , Taught by Sy Truong, ... new “CDISC Standards: Theory and Application” class will give ...
Breaking Biology Technology:New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3Clinovo Launches TechTrainings on CDISC Standards 2
... onset seizure reduction, proven tolerability, and ... - Keppra XR(TM) is built on ... regulated information:,UCB announced today that the U.S. Food and Drug ... as,an add-on to other antiepileptic treatments for people with partial-onset,seizures ...
... 12 Exosome Diagnostics, Inc. today,announced the appointment ... In this role, Dr. Skog will oversee the ... blood-based diagnostics that can,identify cancer-specific genetic mutations., ... of Exosome Diagnostics,core technology that has been licensed ...
... - Upfront, milestone payments and promotional investment totaling up to ... ... 12 CV Therapeutics,Inc. (Nasdaq: CVTX ) announced today ... Ranexa(R) (ranolazine prolonged release,tablets) in Europe and other countries to ...
Cached Biology Technology:Video: Keppra XR(TM) Approved in the U.S. 2Video: Keppra XR(TM) Approved in the U.S. 3Video: Keppra XR(TM) Approved in the U.S. 4CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 2CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 3CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 4CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 5
(Date:5/20/2013)... planning grant will help establish the Center for Advanced ... University of Illinois at Urbana-Champaign and Worcester Polytechnic Institute ... to research in drying moist, porous materials such as ... chemical products; textiles; and biopharmaceuticals," said Hao Feng, a ... nutrition and the Illinois site director. , According to ...
(Date:5/20/2013)... the University of Bristol and published online today in ... on how the brain and inner ear developed in ... Earth Sciences, together with Tom Hbner from the Niederschsische ... million year old dinosaurs. , The two palaeontologists studied ... : a very young (juvenile) individual of approximately ...
(Date:5/19/2013)... white men and women of European descent inherit common ... toe deformities, including hammer or claw toe. Findings from ... of foot disorders in humansappear in Arthritis Care ... behalf of the American College of Rheumatology (ACR). ... of older adults have foot disorders which may limit ...
Breaking Biology News(10 mins):NSF approves planning grant for Center for Advanced Research in Drying 2Fossil brain teaser 2Blame your parents for bunion woes 2
... Highlights: Advanced technologies create ... Radio was integrated easily with Army,s cellular biometric network ... Harris Corporation,s (NYSE: HRS ... infrastructure for various mission scenarios at the Empire Challenge 2011 ...
... 2011 Ceelox, Inc., (OTCBB: CELO), (the "Company"), proudly ... the U.S. Patent Office. The patent, U.S. Patent Number ... Encryption And Decryption" provides the ability to biometrically enable ... data.  Ceelox, latest patent is unique in that it ...
... study from scientists at Queen Mary, University of London, sheds ... go through major surgery, can suffer organ damage in parts ... The study, published today in Nature Immunology *, ... out of blood vessels to defend damaged organs against injury ...
Cached Biology News:Harris Corporation's Highband Networking Radio Provides Mobile, Wideband Communications for Empire Challenge 2011 2Harris Corporation's Highband Networking Radio Provides Mobile, Wideband Communications for Empire Challenge 2011 3Ceelox Vault Patent Issued 2Ceelox Vault Patent Issued 3Rogue blood cells may contribute to post-surgery organ damage 2
... research laboratory, the revolutionary Luminex 100 System ... and in real time enhancing your operational ... includes the Luminex 100, the XY Platform, ... which enables you to simultaneously assay up ...
... is a compact analysis system for the clinical ... a controller, advanced digital signal processing and a ... system includes the Luminex 100, the XY Platform, ... file at the FDA, and partner kits that ...
... quality source of amino acids and ... of casein. It is recommended for ... been used in antibiotics, toxins and ... For microbiology pH6.8 0.5 at 25 ...
... peptone, used in media ... bacterial toxins, and for ... with high nutritional requirements ... Pasteurella, Salmonella and Staphylococcus ...
Biology Products: